CancerX at ASCO 2023

ASCO 2023: Santosh MohanПодробнее

ASCO 2023 – Gregory LubinieckiПодробнее

Exclusive highlights in genitourinary cancer at ASCO 2023Подробнее

Highlights in kidney and bladder cancer at ASCO 2023Подробнее

Highlights at ASCO 2023Подробнее

Moffitt Cancer Center at ASCO 2023Подробнее

Transforming Cancer Care: New Success at ASCO 2023Подробнее

Lung cancer trial updates at ASCO 2023Подробнее

Immunotherapy at ASCO 2023: updates in neoadjuvant and adjuvant therapyПодробнее

Head and neck updates at ASCO 2023Подробнее

ASCO 2023: Driving Innovation in Cancer CareПодробнее

What to look forward to in breast cancer at ASCO 2023Подробнее

Dr. Andrew Brohl at ASCO 2023: Abstract No. 9534Подробнее

Lung cancer at ASCO 2023: ADAURA and ADCsПодробнее

ASCO 2023 | The evolving landscape in precision oncologyПодробнее

ASCO 2023: Dr. Roger LiПодробнее

ASCO 2023: Dr. Luis E. AguirreПодробнее

ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trialПодробнее